Last Updated: May 15, 2026
All content on this site is provided for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Before starting, changing, or stopping any medication or health program—including GLP-1 therapies—consult a licensed healthcare professional who knows your full medical history.
Using or browsing this site does not create a doctor–patient, pharmacist–patient, or any other healthcare provider–patient relationship. This site is an independent editorial comparison resource—not a healthcare provider, pharmacy, telehealth service, or prescriber.
Certain GLP-1 medications are FDA-approved for specific indications under brand names (e.g., Wegovy®, Ozempic®, Mounjaro®, Zepbound®). These are prescription drugs that may only be dispensed pursuant to a valid prescription issued by a licensed clinician. This site does not prescribe, dispense, or facilitate the dispensing of any medication.
Compounded versions of semaglutide and tirzepatide have been subject to FDA regulatory actions and shortage-status changes. FDA-approved branded products and compounded versions are distinct products with different regulatory statuses. Always confirm the regulatory and approval status of any medication with your prescribing clinician and pharmacist.
This site makes no representation that any GLP-1 program, product, or service will produce specific weight-loss outcomes. Individual results vary significantly and depend on factors including health status, adherence, lifestyle, dosage, and prescriber guidance. Nothing on this site should be interpreted as a promise or guarantee of any particular outcome.
If you are experiencing a medical emergency, call your local emergency services (e.g., 911 in the U.S.) immediately. Do not rely on this website for urgent medical guidance.